Meningococcal Conjugate Vaccine (GSK)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Meningococcal Conjugate Vaccine (GSK), covering 2019-08-06 to 2019-08-06. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers [Phase 3]